Skip to main content
SpringerLink
Log in

Biology of the protein kinase C family

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Abstract

Protein kinase C (PKC) is composed of a family of isozymes that transduce signals of certain hormones, growth factors, lectins, and neurotransmitters. This review addresses the role of PKC in the regulation of cellular proliferation and its disorders. PKC is directly activated in vivo by the second messenger diacylglycecrol, a lipid produced by phospholipase C-catalyzed hydrolysis of phosphatidylinositol and polyphosphoinositides. Diacylglycerol activates PKC by reducing the enzyme's requirement for Ca2+. Phorbol ester tumor promoters and related agents potently activate PKC by a mechanism analogous to that of diacylglycerol, providing evidence that PKC activation is a critical event in tumor promotion. However, the role of PKC activation in tumor promotion is not entirely clear. For example, bryostatin is a potent PKC activator that antagonizes phorbol ester-mediated tumor promotion, and mezerein is a second-stage tumor promoter that potently activates PKC. In addition to studies concerned with tumor promotion, studies of oncogene action also indicate a role for PKC in carcinogenesis. A number of plasma membrane-associated oncogene products and related proteins are PKC substrates, and PKC activation leads to induction of the expression of oncogenes that code for nuclear proteins. PKC is implicated in human breast and colon carcinogenesis. tumor-promoting bile acids activate PKC, and PKC expression studies in rat colonic epithelial cells and human breast cancer cells indicate a positive role for PKC in the proliferation of the cells. Altered expression of PKC in human colon and breast tumors indicates that PKC isozymes may be useful markers for these diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Nishizuka Y: The molecular heterogenecity of protein kinase C and its implications for cellular regulation. Nature 334: 661–665, 1988

    Google Scholar 

  2. Coussens L, Parker PJ, Rhee L, Yang-Feng TL, Chen E, Waterfield MD, Francke U, Ullrich A. Multiple, distinct forms of bovine and human protein kinase C suggest diversity in cellular signaling pathways. Science 233: 859–866, 1986

    Google Scholar 

  3. Knopf JL, Lee MH, Sultzman LA, Kriz RW, Loomis CR, Hewick RM, Bell RM: Cloning and expression of multiple protein kinase C cDNAs. Cell 46: 491–502, 1986

    Google Scholar 

  4. Housey GM, O'Brian CA, Johnson MD, Kirschmeier P, Weinstein IB: Isolation of cDNA clones encoding protein kinase C: Evidence for a protein kinase C-related gene family. Proc Natl Acad Sci USA 84: 1065–1069, 1987

    Google Scholar 

  5. Michell R: Inositol phospholipids and cell surface receptor function. Biochim Biophys Acta 415: 81–147, 1975

    Google Scholar 

  6. Berridge MJ: Inositol trisphosphate and diacylglycerol: two interacting second messengers. Ann Rev Biochem 56: 159–193, 1987

    Google Scholar 

  7. Nishizuka Y: Studies and perspectives of protein kinase C. Science 233: 305–312, 1986

    Google Scholar 

  8. Huang KP, Nakabayashi H, Huang FL: Isozymic forms of rat brain Ca2+-activated and phospholipid-dependent protein kinase. Proc Natl Acad Sci USA 83: 8535–8539, 1986

    Google Scholar 

  9. Jaken S, Kiley SC: Purification and characterization of three types of protein kinase C from rabbit brain cytosol. Proc Natl Acad Sci USA 84: 4418–4422, 1987

    Google Scholar 

  10. Huang FL, Yoshida Y, Nakabayashi H, Knopf JL, Young WS, Huang KP: Immunochemical identification of protein kinase C isozymes as products of discrete genes. Biochem Biophys Res Commun 149: 946–952, 1987

    Google Scholar 

  11. Inoue M, Kishimoto A, Takai Y, Nishizuka Y: Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. J Biol Chem 252: 7610–7616, 1977

    Google Scholar 

  12. Kishimoto A, Kajikawa N, Shiota M, Nishizuka Y: Proteolytic activation of calcium-activated, phospholipid-dependent protein kinase by calcium-dependent neutral protease. J Biol Chem 258: 1156–1164, 1983

    Google Scholar 

  13. House C, Kemp BE: Protein kinase C contains a pseudosubstrate prototope in its regulatory domain. Science 238: 1726–1728, 1987

    Google Scholar 

  14. Granot J, Mildvan AS, Hiyama K, Kondo H, Kaiser ET: Magnetic resonance studies of the effect of the regulatory subunit on metal and substrate binding to the catalytic subunit of bovine heart protein kinase. J Biol Chem 255: 4569–4573, 1980

    Google Scholar 

  15. Granot J, Mildvan AS, Kaiser ET: Studies of the mechanism of action and regulation of cAMP-dependent protein kinase. Arch Biochem Biophys 205: 1–17, 1980

    Google Scholar 

  16. Pearson RB, Wettenhall REH, Means AR, Hartshorne DJ, Kemp BE: Autoregulation of enzymes by pseudosubstrate prototopes: Myosin light chain kinase. Sci 241: 970–973, 1988

    Google Scholar 

  17. Kishimoto A, Takai Y, Mori T, Kikkawa U, Nishizuka Y: Activation of calcium and phospholipid-dependent protein kinase by diacylglycerol, its possible relation to phosphatidylinositol turnover. J Biol Chem 255: 2273–2276, 1980

    Google Scholar 

  18. Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y: Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 257: 7847–7851, 1982

    Google Scholar 

  19. Wise BC, Raynor RL, Kuo JF: Phospholipid-sensitive Ca2+ dependent protein kinase from heart. J Biol Chem 257: 8481–8488, 1982

    Google Scholar 

  20. Arcoleo JP, Weinstein IB: Activation of protein kinase C by tumor promoting phorbol esters, teleocidin and aplysiatoxin in the absence of added calcium. Carcinogenesis 6: 213–217, 1985

    Google Scholar 

  21. Parker PJ, Stabel S, Waterfield MD: Purification to homogeneity of protein kinase C from bovine brain-identity with the phorbol ester receptor. EMBO (3): 953–959, 1984

  22. Parker PJ, Coussens L, Totty N, Rhee L, Young S, Chen E, Stabel S, Waterield MD, Ullrich A: The complete primary structure of protcin kinase C-the major phorbol ester tumor promoter receptor. Sci 233: 853–859, 1986

    Google Scholar 

  23. Weinstein IB: The origins of human cancer: Molecular mechanisms of carcinogenesis and their implication for cancer prevention and treatment. Cancer Res 48: 4135–4143, 1988

    Google Scholar 

  24. Jensen DE, Sando JJ: Absence of protein kinase C in nuclei of EL4 mouse thymoma cells. Cancer Res 47: 3868–3872, 1987

    Google Scholar 

  25. Kikkawa U, Minakuchi R, Takai Y, Nishizuka Y: Calcium-activated, phospholipid-dependent protein kinase (protein kinase C) from rat brain. Methods Enzymol 99: 288–298, 1983

    Google Scholar 

  26. O'Brian CA, Lawrence DS, Kaiser ET, Weinstein IB: Protein kinase C phosphorylates the synthetic peptide Arg-Lys-Arg-Ala-Ser-Gly-Pro-Pro-Val in the presence of phospholipid plus either Ca2+ or a phorbol ester tumor promoter. Biochem Biophys Res Commun 124: 296–302, 1984

    Google Scholar 

  27. Turner RS, Kemp BS, Su H, Kuo JF: Substrate specificity of phospholipid/Ca2+-dependent protein kinase as probed with synthetic peptide fragments of the bovine myelin basic protein. J Biol Chem 260: 11503–11507, 1985

    Google Scholar 

  28. Woodgett JR, Gould KL, Hunter T: Substrate specificity of protein kinase C: Use of synthetic peptides corresponding to physiological sites as probes for substrate recognition requirements. Eur J Biochem 161: 177–184, 1986

    Google Scholar 

  29. DeBont HBA, Liskamp RMJ, O'Brian CA, Erkelens C, Veeneman GH, Van Boom JH: Synthesis of substrate of protein kinase C and its corresponding phosphopeptide. Int J Pept Prot Res 33: 115–123, 1989

    Google Scholar 

  30. Hunter T, Ling N, Cooper JA: Protein kinase C phosphorylation of the EGF receptor at a threonine residue close to the cytoplasmic face of the plasma membrane. Nature 311: 480–483, 1984

    Google Scholar 

  31. Bollag GE, Roth RA, Beaudoin J, Mochly-Rosen D, Koshland DE: Protein kinase C directly phosphorylates the insulin receptor in vitro and reduces its protein-tyrosine kinase activity. Proc Natl Acad Sci USA 83: 5822–5824, 1986

    Google Scholar 

  32. Carpenter G: Receptors for epidermal growth factor and other polypeptide mitogens. Ann Rev Biochem 56: 881–914, 1987

    Google Scholar 

  33. Werth DK, Niedel JE, Pastan I: Vinculin, a cytoskeletal substrate of protein kinase C. J Biol Chem 258: 11423–11426, 1983

    Google Scholar 

  34. Ballester R, Furth ME, Rosen OM: Phorbol ester- and protein kinase C-mediated phosphorylation of the cellular kirsten ras gene product. J Biol Chem 262: 2688–2695, 1987

    Google Scholar 

  35. Zwiller J, Revel MO, Malviya AN: Protein kinase C catalyzes phosphorylation of guanylate cyclase in vitro. J Biol Chem 260: 1350–1353, 1985

    Google Scholar 

  36. Connolly TM, Lawing WJ, Majerus PW: Protein kinase C phosphorylates human platelet inositol trisphosphate 5′-phosphomonoesterase, increasing the phosphatase activity. Cell 46: 951–958, 1986

    Google Scholar 

  37. Ikebe M, Hartshorne DJ, Elzinga M: Phosphorylation of the 20,000-dalton light chain of smooth muscle myosin by the calcium-activated, phospholipid-dependent protein kinase. J Biol Chem 262: 9569–9573, 1987

    Google Scholar 

  38. Farese RV: Calcium as an intracellular mediator of hormone action: Intracellular phospholipid signaling systems. Am J Medic Sci 296: 223–230, 1988

    Google Scholar 

  39. Majerus PW, Connolly TM, Bansal VS, Inhorn RC, Ross TS, Lips DL: Inositol phosphates: Synthesis and degradation. J Biol Chem 263: 3051–3054, 1988

    Google Scholar 

  40. Hill TD, Dean NM, Boynton AL: Inositol 1,3,4,5-tetrakisphosphate induces Ca2+ sequestration in rat liver cells. Sci 242: 1176–1178, 1988

    Google Scholar 

  41. Whitman M, Downes CP, Keeler M, Keller T, Cantley L: Type 1 phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate. Nature 332: 644–646, 1988

    Google Scholar 

  42. Auger KR, Serunian LA, Soltoff SR, Libby P, Cantley LC. PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells. Cell 57: 167–175, 1989

    Google Scholar 

  43. Mori T, Takai Y, Yu B, Takahashi J, Nishizuka Y, Fujikura T: Specificity of the fatty acyl moieties of diacylglycerol for the activation of calcium-activated, phospholipid-dependent protein kinase. J Biochem 91: 427–431, 1982

    Google Scholar 

  44. Fischer SM, Reiners JJ, Pence BC, Aldaz CM, Conti CJ, Morris RJ, O'Connell JF, Rotstein JB, Slaga TJ: Mechanisms of carcinogenesis using mouse skin: The multistage assay revisted. Progress in Can Res and Therapy 34: 11–30, 1988

    Google Scholar 

  45. Slaga TJ, O'Connell J, Rotstein J, Patskan G, Morris R, Aldaz CM, Conti CJ: Critical genetic determinants and molecular events in multistage skin carcinogenesis. In: Becker FF, Slaga TJ (eds) Critical Molecular Determinants of Carcinogenesis. University of Texas Press, Austin, Tx. 1987, pp 31–44

    Google Scholar 

  46. Hennings H. Variable potential for malignant conversion of papillomas induced by initiation-promotion protocols. Progress in Cancer Res and Ther 34: 31–50, 1988

    Google Scholar 

  47. Weinstein IB: Studies on the mechanims of action of tumor promoters and their relevance to mammary carcinogenesis. In: McGrath CM, Brennar MJ, Rich MA (eds) Cell Biology of Breast Cancer. Academic Press, N.Y., 1981, pp 425–450

    Google Scholar 

  48. Fujiki H, Tanaka Y, Miyake R, Kikkawa U, Nishizuka Y, Sugimura T: Activation of calcium-activated, phospholipid-dependent protein kinase (protein kinase C) by new classes of tumor promoters: teleocidin and debromoaplysiatoxin. Biochem Biophys Res Commun 120: 339–343, 1984

    Google Scholar 

  49. Flockhart DA, Corbin JD: Regulatory mechanisms in the control of protein kinases. CRC Crit Rev Biochem 12: 133–186, 1982

    Google Scholar 

  50. Miyake R, Tanaka Y, Tsuda T, Kaibuchi K, Kikkawa U, Nishizuka Y: Activation of protein kinase C by nonphorbol tumor promoter mezerein. Biochem Biophys Res Commun 121: 649–656, 1984

    Google Scholar 

  51. Gschwendt M, Horn F, Kittstein W, Furstenberger G, Besemfelder E, Marks F: Calcium and phospholipid-dependent protein kinase activity in mouse epidermal cytosol. Stimulation by complete and incomplete tumor promoters and inhibition by various compounds. Biochem Biophys Res Commun 124: 63–68, 1984

    Google Scholar 

  52. Couturier A, Bazgar S, Castagna M: Further characterization of tumor promoter-mediated activation of protein kinase C. Biochem Biophys Res Commun 121: 448–455, 1984

    Google Scholar 

  53. Fujiki H, Suganuma M, Suguri H, Yoshizawa S, Hirota M, Takagi K, Sugimura T: Diversity in chemical nature of and mechanism of response to tumor promoters. In: Slaga TJ (ed) Dermal Carcinogenesis, Research Directions for Human Relevance. Raven Press, N.Y., 1988

    Google Scholar 

  54. Sako T, Tauber AJ, Jeng AY, Yuspa SH, Blumberg PM: Contrasting actions of staurosporine, a protein kinase C inhibitor, on human neutrophils and primary mouse epidermal cells. Cancer Res 48: 4646–4650, 1988

    Google Scholar 

  55. Hennings H, Blumberg P, Pettit GR, Herald CL, Shores R, Yuspa SH: Bryostatin 1, an activator of protein kinase C, inhibits tumor promotion by phorbol esters in SENCAR mouse skin. Carcinogenesis 8: 1343–1346, 1987

    Google Scholar 

  56. Kraft AS, Smith JB, Berkow RL: Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60. Proc Natl Acad Sci USA 83: 1334–1338, 1986

    Google Scholar 

  57. Sako T, Yuspa SH, Herald CL, Pettit GR, Blumberg PM: Partial parallelism and partial blockade by bryostatin 1 of effects of phorbol ester tumor promoters on primary mouse epidermal cells. Cancer Res 47: 5445–5450, 1987

    Google Scholar 

  58. McBain JA, Pettit G, Mueller GC: Bryostatin 1 antagonizes the terminal differentiating action of 12–0-tetradecanoylphorbol-13-acetate in a human colon cancer cell line. Carcinogenesis 9: 123–129, 1988

    Google Scholar 

  59. Wender PA, Cribbs CM, Koehler KF, Sharkey NA, Herald CL, Kamano Y, Pettit GR, Blumberg PM: Modeling of the bryostatins to the phorbol ester pharmacophore on protein kinase C. Proc Natl Acad Sci USA 85: 7197–7201, 1988

    Google Scholar 

  60. DeVries DJ, Herald CL, Pettit G, Blumberg P: Demonstration of subnanomolar affinity of bryostatin 1 for the phorbol ester receptor in rat brain. Biochem Pharmacol 37: 4069–4073, 1988

    Google Scholar 

  61. Fischer SM, Baldwin JK, Jasheway DW, Patrick KE, Cameron GS: Phorbol ester induction of 8-lipoxygenase in inbred SENCAR (SSIN) but not C57BL/6J mice correlated with hyperplasia, edema, and oxidant generation but not ornithine decarboxylase induction. Cancer Res 48: 658–664, 1988

    Google Scholar 

  62. Emerit I, Cerutti PA: Tumor promoter phorbol 12-myristate 13-acetate induces a clastogenic factor in human lymphocytes. Proc Natl Acad Sci USA 79: 7509–7513, 1982

    Google Scholar 

  63. Ames BN: Dietary carcinogens and anticarcinogens. Science 221: 1256–1264, 1983

    Google Scholar 

  64. Pontremoli S, Melloni E, Michetti M, Sacco O, Salamino F, Sparatore B, Horecker BL: Biochemical responses in activated human neutrophils mediated by protein kinase C and a Ca2+-requiring protease. J Biol Chem 261: 8309–8313, 1986

    Google Scholar 

  65. McPhail LC, Clayton CC, Snyderman R: A potential second messenger role for unsaturated fatty acids: Activation of Ca2+-dependent protein kinase. Science 224: 622–625, 1984

    Google Scholar 

  66. Fujiki H, Suganuma M, Nakayasu M, Hakii H, Horiuchi T, Takayama S, Sugimura T: Palytoxin is a non-12–0-tetradecanoylphorbol-13-acetate type tumor promoter in two-stage mouse skin carcinogenesis. Carcinogenesis 7: 707–710, 1986

    Google Scholar 

  67. O'Brian CA, Ward NE, Weinstein IB, Bull AW, Marnett LJ: Activation of rat brain protein kinase C by lipid oxidation products. Biochem Biophys Res Commun 155: 1374–1380, 1988

    Google Scholar 

  68. Hansson A, Serhan CN, Haeggstrom J, Ingelman-Sundberg M, Samuelsson B: Activation of protein kinase C by lipoxin A and other eicosanoids. Intracellular action of oxygenation products of arachidonic acid. Biochem Biophys Res Commun 134: 1215–1222, 1986

    Google Scholar 

  69. Naor Z, Shearman MS, Kishimoto A, Nishizuka Y: Calcium independent activation of hypothalamic type 1 protein kinase C by unsaturated fatty acids. Molec Endocrinol 2: 1043–1048, 1988

    Google Scholar 

  70. Shearman MS, Naor Z, Sekiguchi K, Kishimoto A, Nishizuka Y: Selective activation of the γ-subspecies of protein kinase C from bovine cerebellum by arachidonic acid and its lipoxygenase metabolites. FEBS Letts 243: 177–182, 1989

    Google Scholar 

  71. Gould KL, Woodgett JR, Cooper JA, Buss JE, Shalloway D, Hunter T: Protein kinase C phosphorylates pp60src at a novel site. Cell 42: 849–857, 1985

    Google Scholar 

  72. McCormick F: Ras GTPase activating protein: signal transmitter and signal terminator. Cell 56: 5–8, 1989

    Google Scholar 

  73. Hunter T: A thousand and one protein kinases. Cell 50: 823–829, 1987

    Google Scholar 

  74. Gould KL, Woodgett JR, Isacke CM, Hunter T: The protein-tyrosine kinase substrate p36 is also a substrate for protein kinase C in vitro and in vivo. Molec. and Cellular Biol 6: 2738–2744, 1986

    Google Scholar 

  75. Rabin MS, Doherty PJ, Gottesman MM: The tumor promoter phorbol 12-myristate 13-acetate induces a program of altered gene expression similar to that induced by platelet-derived growth factor and transforming oncogenes. Proc Natl Acad Sci USA 83: 357–360, 1986

    Google Scholar 

  76. Muramatsu MA, Kaibuchi K, Arai KI: A protein kinase C cDNA without the regulatory domain is active after transfection in vivo in the absence of phorbol ester. Molec Cell Biol 9: 831–836, 1989

    Google Scholar 

  77. Wolfman A, Wingrove TG, Blackshcar PJ, Macara IG: Down-regulation of protein kinase C and of an endogenous 80K-Da substrate in transformed fibroblasts. J Biol Chem 262: 16546–16552, 1987

    Google Scholar 

  78. Weyman CM, Taparowsky EJ, Wolfson M, Ashendel CL: Partial downregulation of protein kinase C in C3H 10T 1/2 mouse fibroblasts transfected with the human Ha-ras oncogene. Cancer Res 48: 6535–6541, 1988

    Google Scholar 

  79. Fleischman LF, Chahwala SB, Cantley L: Ras-transformed cells: altered levels of phosphatidylinositol-4,5-bisphosphate and catabolites. Science 231: 407–410, 1986

    Google Scholar 

  80. Lacal JC, de la Pena P, Moscat J, Garcia-Barreno P, Anderson PS, Aaronson SA. Rapid stimulation of dia cylglycerol production in Xenopus oocytes by microinjection of H-ras p21. Science 238: 533–536, 1987

    Google Scholar 

  81. Young S, Rothbard J, Parker PJ: A monoclonal antibody recognizing the site of limited proteolysis of protein kinase C. Eur J Biochem 173: 247–252, 1988

    Google Scholar 

  82. Housey GM, Johnson MD, Hsiao WLW, O'Brian CA, Murphy JP, Kirschmeier P, Weinstein IB: Overproduction of protein kinase C causes disordered growth control in rat fibroblasts. Cell 52: 343–354, 1988

    Google Scholar 

  83. Persons DA, Wilkison WO, Bell RM, Finn OJ: Altered growth regulation and enhanced tumorigenicity of N1H3T3 fibroblasts transfected with protein kinase C-1 cDNA. Cell 52: 447–458, 1988

    Google Scholar 

  84. Ishikawa F, Takaku F, Nagao M, Sugimura T: Cysteinerich regions conserved in amino-terminal halves of raf gene family products and protein kinase C. Gann 77: 1183–1187, 1986

    Google Scholar 

  85. Reddy BS, Watanabe K, Weisburger JH, Wynder EL: Promoting effect of bile acids in colon carcinogenesis in germ-free and conventional rats. Cancer Res 37: 3238–3242, 1977

    Google Scholar 

  86. Reddy BS, Narasawa T, Weisburger JH, Wynder EL: Promoting effect of sodium deoxycholate on colon adenocarcinomas in germ-free rats. J Natl Canc Inst 56: 441–442, 1976

    Google Scholar 

  87. Cameron RG, Imaida K, Tsuda H, Ito N: Promotive effects of steroids and bile acids on hepatocarcinogenesis initiated by diethylnitrosamine. Cancer Res 42: 2426–2428, 1982

    Google Scholar 

  88. Furihata C, Takezawa R, Matsushima T, Tatematsu M: Potential tumor-promoting activity of bile acids in glandular stomach. Gann 78: 32–39, 1987

    Google Scholar 

  89. Kaibara N, Yurugi E, Koga S: Promoting effect of bile acids on the chemical transformation of C3H 10T 1/2 fibroblasts in vitro. Cancer Res 44: 5482–5485, 1984

    Google Scholar 

  90. Guillem JG, Matsui MS, O'Brian CA: Nutrition in the prevention of neoplastic disease in the elderly. Clinics in Geriatric Medic 3: 373–387, 1987

    Google Scholar 

  91. Wargovich MJ, Eng VWS, Newmark HL, Bruce WR: Calcium ameliorates the toxic effect of deoxycholic acid on colonic epithelium. Carcinogen 4: 1205–1207, 1983

    Google Scholar 

  92. Wargovich MJ, Eng VWS, Newmark HL, Bruce WR: Calcium modification of the promoting stimulus of fatty acids to the colonic epithelium. Canc Letts 23: 256–261, 1984

    Google Scholar 

  93. Fitzer CJ, O'Brian CA, Guillem JG, Weinstein IB: The regulation of protein kinase C by chenodeoxycholate, deoxycholate, and several structurally related bile acids. Carcinogen 8: 217–220, 1987

    Google Scholar 

  94. Ward NE, O'Brian CA. The bile acid analog fusidic acid can replace phosphatidylserine in the activation of protein kinase C by 12–0-tetradecanoylphorbol-13-acetate in vitro. Carcinogen 9: 1451–1454, 1988

    Google Scholar 

  95. Takenawa T, Nagai Y: Purification of phosphatidylinositol-specific phospholipase C from rat liver. J Biol Chem 256: 6769–6775, 1981

    Google Scholar 

  96. Craven PA, Pfanstiel J, DeRubertis FR: Role of activation of protein kinase C in the stimulation of colonic epithelial proliferation and reactive oxygen formation by bile acids. J Clinic Investig 79: 532–541, 1987

    Google Scholar 

  97. Guillem JG, O'Brian Ca, Fitzer CJ, Johnson MD, LoGerfo P, Forde KA, Weinstein IB: Studies on protein kinase C and colon carcinogenesis. Arch. Surgery 122: 1475–1478, 1987

    Google Scholar 

  98. Guillem JG, O'Brian CA, Fitzer CJ, Forde KA, LoGerfo P, Treat M, Weinstein IB: Altered levels of protein kinase C and Ca2.-dependent protein kinases in human colon carcinomas. Cancer Res 47: 2036–2039, 1987

    Google Scholar 

  99. Horn F, Marks F, Fisher G, Marcelo CL, Voorhees JJ: Decreased protein kinase C activity in psoriatic versus normal epidermis. J Investig Dermatol 88: 220–222, 1987

    Google Scholar 

  100. Gescher A: Antiproliferative properties of phorbol ester tumor promoters. Biochem Pharmacol 34: 2587–2592, 1985

    Google Scholar 

  101. Craven PA, DeRubertis FR: Subcellular distribution of protein kinase C in rat colonic epithelial cells with different proliferative activities. Cancer Res 47: 3434–3438, 1987

    Google Scholar 

  102. Darbon JM, Valette A, Bayard F: Phorbol esters inhibit the proliferation of MCF-7 cells. Biochem Pharmacol 35: 2683–2686, 1986

    Google Scholar 

  103. Regazzi R, Fabbro D, Costa SD, Borner C, Eppenberger U. Effects of tumor promoters on growth and on cellular redistribution of phospholipid/Ca2+-dependent protein kinase in human breast cancer cells. Int J Cancer 37: 731–737, 1986

    Google Scholar 

  104. Fabbro D, Regazzi R, Costa SD, Borner C, Eppenberger U: Protein kinase C desensitization by phorbol esters and its impact on growth of human breast cancer cells. Biochem Biophys Res Commun 135: 65–73, 1986

    Google Scholar 

  105. Costa SD, Fabbro D, Reggazzi R, Kung W, Eppenberger U: The cytosolic phorboid receptor correlates with hormone dependency in six mammary carcinoma cell lines. Biochem Biophys Res Commun 133: 814–822, 1985

    Google Scholar 

  106. Fabbro D, Kung W, Roos W, Regazzi R, Eppenberger U: Epidermal growth factor binding and protein kinase C activities in human breast cancer cell lines: Possible quantitative relationship. Cancer Res 46: 2720–2725, 1986

    Google Scholar 

  107. Borner C, Wyss R, Regazzi R, Eppenberger U, Fabbro D: Immunological quantitation of phospholipid/Ca2--dependent protein kinase of human mammary carcinoma cells: Inverse relationship to estrogen receptors. Int J Cancer 40: 344–348, 1987

    Google Scholar 

  108. Wyss R, Fabbro D, Regazzi R, Borner C, Takahashi A, Eppenberger U: Phorbol ester and epidermal growth factor receptors in human breast cancer. Anticancer Res 7: 721–728, 1987

    Google Scholar 

  109. O'Brian CA, Vogel VG, Singletary SE, Ward NE: Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue. Cancer Res 49: 3215–3217, 1989

    Google Scholar 

  110. Mourisden H, Palshof T, Patterson J, Battersby L: Tamoxifen in advanced breast cancer. Cancer Treat Rev 5: 131–141, 1978

    Google Scholar 

  111. Daniel CP, Gaskell SJ, Bishop H, Campbell C, Nicolson RI: Determination of tamoxifen and biologically active metabolites in human breast tumors and plasma. Eur J Cancer Clin Oncol 17: 1183–1189, 1981

    Google Scholar 

  112. O'Brian CA, Liskamp RM, Solomon DH, Weinstein IB: Inhibition of protein kinase C by tamoxifen. Cancer Res 45: 2462–2465, 1985

    Google Scholar 

  113. Su HD, Mazzei GJ, Vogler WR, Kuo JF: Effect of tamoxifen, a nonsteriodal antiestrogen, on phospholipid/calcium-dependent protein kinase and phosphorylation of its endogenous substrate proteins from the rat brain and ovary. Biochem Pharmacol 34: 3649–3653, 1985

    Google Scholar 

  114. O'Brian CA, Liskamp RM, Solomon DH, Weinstein IB: Triphenylethylenes: A new class of protein kinase C inhibitors. J Natl Cancer Inst 76: 1243–1246, 1986

    Google Scholar 

  115. O'Brian CA, Housey GM, Johnson MD, Kirschmeier P, Liskamp RM, Weinstein IB: The mechanism of action of protein kinase C: new insights through the study of inhibitors and gene cloning. Progr in Cancer Res and Therapy 34: 343–356, 1988

    Google Scholar 

  116. Lam HYP: Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase. Biochem Biophys Res Commun 118: 27–32, 1984

    Google Scholar 

  117. O'Brian CA and Weinstein IB: In vitro inhibition of rat brain protein kinase C by rhodamine 6G: Profound effects of the lipid cofactor on the inhibition of the enzyme. Biochem Pharmacol 36: 1231–1235, 1987

    Google Scholar 

  118. O'Brian CA, Housey GM and Weinstein IB: Specific and direct binding of protein kinase C to an immobilized tamoxifen analogue. Cancer Res 48: 3626–3629, 1988

    Google Scholar 

  119. O'Brian CA, Housey GM, Weinstein IB: Binding of protein kinase C to naphthalene-sulfonamide and phenothiazine agarose columns: evidence for direct interactions between protein kinase C and cationic amphiphilic inhibitors of the enzyme. Biochem Pharmacol 36: 4179–4181, 1987

    Google Scholar 

  120. O'Brian CA, Ward NE, Anderson BW: Role of specific interactions between protein kinase C and triphenylethylenes in inhibition of the enzyme. J Natl Cancer Inst 80: 1628–1633, 1988

    Google Scholar 

  121. O'Brian CA, Ward NE: Binding of protein kinase C to N-(6-aminohexyl) 5-chloro 1-naphthalenesulfonamide through its ATP binding site. Biochem Pharmacol, in press.

  122. Tsuruo T: Mechanisms of multidrug resistance and implications for therapy. Jpn J Cancer Res 79: 285–296, 1988

    Google Scholar 

  123. Moscow JA, Cowan KH: Multidrug resistance. J Natl Cancer Inst 80: 14–20, 1988

    Google Scholar 

  124. Ferguson PJ and Cheng Y: Transient protection of cultured human cells against antitumor agents by 12–0-tetradecanoyl-phorbol-13-acetate. Cancer Res 47: 433–441, 1987

    Google Scholar 

  125. Fine RL, Patel J, Chabner BA: Phorbol esters induce multidrug resistance in human breast cancer cells. Proc Natl Acad Sci 85: 582–586, 1988

    Google Scholar 

  126. Akiyama S, Shiraishi N, Kuratomi Y, Nakagawa M, Kuwano M: Circumvention of multiple-drug resistance in human cancer cells by thioridazine, trifluoperazine, and chlorpromazine. J Natl Cancer Inst 76: 839–844, 1986

    Google Scholar 

  127. O'Brian CA, Fan D, Ward NE, Seid C, Fidler IJ: Level of protein kinase C activity correlates directly with resistance to adriamycin in murine fibrosarcoma cells. FEBS Letts 246: 78–82, 1989

    Google Scholar 

  128. Aquino A, Hartman KD, Knode MC, Grant S, Huang KP, Niu CH, Glazer RI: Role of protein kinase C in phosphorylation of vinculin in adriamycin-resistant HL-60 leukemia cells. Cancer 48: 3324–3329, 1988

    Google Scholar 

  129. Hamada H, Hagiwara KI, Nakajima T, Tsuruo T: Phosphorylation of the Mr 170,000 to 180,000 glycoprotein specific to multidrug-resistant tumor cells: effects of verapamil, trifluoperazine, and phorbol esters. Cancer Res 47: 2860–2865, 1987

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cell Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA

    Catherine A. O'Brian & Nancy E. Ward

Authors
  1. Catherine A. O'Brian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nancy E. Ward
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

O'Brian, C.A., Ward, N.E. Biology of the protein kinase C family. Cancer Metast Rev 8, 199–214 (1989). https://doi.org/10.1007/BF00047337

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00047337

Key words

Search

Navigation